leukemia, myeloid, acute (99)
precursor cell lymphoblastic leukemia-lymphoma (56)
antineoplastic agents (52)
antineoplastic combined chemotherapy protocols (29)
leukemia, myelogenous, chronic, bcr-abl positive (27)
myelodysplastic syndromes (27)
protein kinase inhibitors (20)
mutation (15)
pyrimidines (15)
hematopoietic stem cell transplantation (12)
leukemia, myeloid, chronic-phase (12)
inotuzumab ozogamicin (11)
mastocytosis, systemic (11)
neoplasms (11)
piperazines (11)
hematologic neoplasms (10)
myeloproliferative disorders (10)
precursor t-cell lymphoblastic leukemia-lymphoma (10)
sulfonamides (10)
enzyme inhibitors (9)
fms-like tyrosine kinase 3 (9)
leukemia (9)
leukemia, myeloid (9)
bridged bicyclo compounds, heterocyclic (8)
neoplasm recurrence, local (8)
staurosporine (8)
antineoplastic agents, immunological (7)
chronic myeloid-leukemia (7)
drug resistance, neoplasm (7)
induction chemotherapy (7)
precursor b-cell lymphoblastic leukemia-lymphoma (7)
protein-tyrosine kinases (7)
pyridazines (7)
apoptosis (6)
bone marrow (6)
imidazoles (6)
acute myeloid-leukemia (5)
antibodies, monoclonal, humanized (5)
asparaginase (5)
cell differentiation (5)
chronic myelomonocytic leukemia (5)
dna-binding proteins (5)
leukemia, myeloid, chronic (5)
leukemia, myelomonocytic, chronic (5)
salvage therapy (5)
chromosome deletion (4)
cytarabine (4)
histone deacetylase inhibitors (4)
immunotherapy, adoptive (4)
janus kinase 2 (4)